CytoMed Therapeutics (GDTC) Earnings Date & Reports
A.I. Advisor
published Earnings
GDTC is expected to report earnings to -3 cents per share on August 28
Q2'24
Est.
$-0.04
Q1'24
Est.
$-0.04
Q4'23
Est.
$-0.05
Q3'23
Beat
by $0.01
Q2'23
Missed
by $0.02
The last earnings report on May 29 showed earnings per share of -3 cents, meeting the estimate of -3 cents. With 2.52K shares outstanding, the current market capitalization sits at 17.89M.